The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas.

Find Out What It Is Right Here.

MLYS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: N/A

Insider Buying (Last 12 Months): $25,100,000.00

Insider Selling (Last 12 Months): $0.00

Mineralys Therapeutics Insider Trading History Chart

Mineralys Therapeutics Share Price & Price History

^$14.72

▲ +0.25 (1.73%)

As of 06/2/2023 01:00 AM ET

Days: 30 | 90 | 365

27 U.S. Cities Where Stocks Yield 26% a Year

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned?

The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.

Mineralys Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/14/2023	Adam Scott Levy	CFO	Buy	6,250	$16.00	$100,000.00	350,811
2/14/2023	Hbm Healthcare Investments (Ca	Major Shareholder	Buy	312,500	$16.00	$5,000,000.00	3,218,106
2/14/2023	Ra Capital Management, L.P.	Director	Buy	1,250,000	$16.00	$20,000,000.00	1,867,229

The Ultimate Passive Income Play

From The Oxford Club | Ad

>>>

SEC Filings (Institutional Ownership Changes) for Mineralys Therapeutics (NASDAQ:MLYS)

Institutional Buying and Selling by Quarter

Mineralys Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2023	SR One Capital Management LP	1,794,600	$28.10M	9.5%	N/A	4.392%
5/18/2023	JPMorgan Chase & Co.	9,269	$0.15M	0.0%	N/A	0.023%
5/18/2023	New York State Common Retirement Fund	3,400	$53K	0.0%	N/A	0.008%
5/16/2023	Sphera Funds Management LTD.	339,000	$5.31M	0.9%	N/A	0.830%
5/16/2023	State Street Corp	134,800	$2.11M	0.0%	N/A	0.330%
5/16/2023	Samsara BioCapital LLC	4,519,361	$70.77M	14.6%	N/A	11.061%
5/16/2023	Geode Capital Management LLC	283,653	$4.44M	0.0%	N/A	0.694%
5/16/2023	Great Point Partners LLC	620,326	$9.71M	1.9%	N/A	1.518%
5/16/2023	Ghisallo Capital Management LLC	10,000	$0.16M	0.0%	N/A	0.024%
5/16/2023	Alyeska Investment Group L.P.	37,500	$0.59M	0.0%	N/A	0.092%
5/16/2023	ArrowMark Colorado Holdings LLC	62,500	$0.98M	0.0%	N/A	0.153%
5/15/2023	Schonfeld Strategic Advisors LLC	88,848	$1.39M	0.0%	N/A	0.217%
5/15/2023	Cubist Systematic Strategies LLC	10,227	$0.16M	0.0%	N/A	0.025%
5/15/2023	Braidwell LP	550,300	$8.62M	0.3%	N/A	1.347%
5/15/2023	Affinity Asset Advisors LLC	62,500	$0.98M	0.3%	N/A	0.153%
5/15/2023	Logos Global Management LP	300,000	$4.70M	0.7%	N/A	0.734%
5/15/2023	Deutsche Bank AG	7,505	$0.12M	0.0%	N/A	0.018%
5/15/2023	Ensign Peak Advisors Inc	125,000	$1.96M	0.0%	N/A	0.306%
5/15/2023	RTW Investments LP	922,100	$14.44M	0.3%	N/A	2.257%
5/12/2023	BlackRock Inc.	749,689	$11.74M	0.0%	N/A	1.835%
5/12/2023	Sectoral Asset Management Inc.	613,233	$9.60M	1.8%	N/A	1.501%
5/12/2023	Bank of America Corp DE	13,990	$0.22M	0.0%	N/A	0.034%
5/12/2023	Prudential Financial Inc.	50,570	$0.79M	0.0%	N/A	0.124%
5/12/2023	Franklin Resources Inc.	450,000	$7.05M	0.0%	N/A	1.101%
5/12/2023	Wellington Management Group LLP	24,224	$0.38M	0.0%	N/A	0.059%
5/12/2023	Charles Schwab Investment Management Inc.	88,960	$1.39M	0.0%	N/A	0.218%
5/11/2023	ExodusPoint Capital Management LP	181,312	$2.84M	0.0%	N/A	0.444%
5/11/2023	American Century Companies Inc.	417,903	$6.53M	0.0%	N/A	1.023%
5/11/2023	Rhumbline Advisers	10,960	$0.17M	0.0%	N/A	0.027%
5/9/2023	Bank of New York Mellon Corp	33,286	$0.52M	0.0%	N/A	0.081%
5/9/2023	California State Teachers Retirement System	4,499	$70K	0.0%	N/A	0.011%
5/5/2023	Monashee Investment Management LLC	110,000	$1.72M	0.5%	N/A	0.269%
5/4/2023	Barclays PLC	12,536	$0.20M	0.0%	N/A	0.031%
4/27/2023	Strs Ohio	2,500	$39K	0.0%	N/A	0.006%

Data available starting January 2016

Mineralys Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Mineralys Therapeutics Inc. is based in RADNOR, Pa.

Today's Range

Now: $14.72

$14.04

$14.83

50 Day Range

MA: $14.63

$12.86

$16.74

52 Week Range

Now: $14.72

$12.62

$21.98

Volume

135,409 shs

Average Volume

84,260 shs

Market Capitalization

$601.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Mineralys Therapeutics?: Mineralys Therapeutics' top insider shareholders include:
Hbm Healthcare Investments (Ca (Major Shareholder)
Ra Capital Management, LP (Director)
Adam Scott Levy (CFO)
Learn More about top insider investors at Mineralys Therapeutics.
Who are the major institutional investors of Mineralys Therapeutics?: Mineralys Therapeutics' top institutional investors include:
Samsara BioCapital LLC — 11.06%
SR One Capital Management LP — 4.39%
RTW Investments LP — 2.26%
BlackRock Inc. — 1.83%
Great Point Partners LLC — 1.52%
Sectoral Asset Management Inc. — 1.50%
Learn More about top institutional investors of Mineralys Therapeutics stock.
Which major investors are buying Mineralys Therapeutics stock?: Within the last quarter, MLYS stock was acquired by institutional investors including:
Samsara BioCapital LLC
SR One Capital Management LP
RTW Investments LP
BlackRock Inc.
Great Point Partners LLC
Sectoral Asset Management Inc.
Braidwell LP
Franklin Resources Inc.
In the previous year, these company insiders have bought Mineralys Therapeutics stock:
Hbm Healthcare Investments (Ca (Major Shareholder)
Ra Capital Management, LP (Director)
Adam Scott Levy (CFO)
Learn More investors buying Mineralys Therapeutics stock.